bioRxiv · 18 Nov 2026
Endothelial VCAM1 links oncogenic KRAS signaling to myeloid inflammation and hemorrhagic instability in brain arteriovenous malformations
Eun S. Parkh-index 20, JungEun Park, Hyejin Park, Ohnmar Myint, Sung Wook Kang, Xian Chen, Zhongming Zhao, Jong Min Choi, Sung Yun Jung, Shuning Huang, Jakob Körbelin, Huimahn Alex Choi, Jaroslaw Aronowski, Peng R. Chen, Eunhee Kimh-index 3
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
BACKGROUND: Hemorrhagic conversion is the most devastating complication of brain arteriovenous malformations (bAVMs). However, endothelial mechanisms promoting macrophages (M{varphi}) recruitment, microglia (MG) activation, and bAVM lesion instability remain unclear. We investigated vascular cell adhesion molecule-1 (VCAM1) as a mediator linking oncogenic endothelial signaling to myeloid cell responses and hemorrhagic progression in bAVMs. METHODS: We performed integrated transcriptomic analysis of human bAVM and epilepsy-control brain tissues, with validation in local bAVM specimens. Transcriptomic and proteomic analyses of bAVM lesions and intact brain tissues from mutant KRAS-induced bAVM mice were followed by histological validation. Using AAV-BR1-KRASG12V-injected Cx3cr1-gfp;Ccr2-rfp mice, we performed intravital imaging to assess M{varphi}/MG responses to VCAM1 neutralization. Hemorrhage and myeloid cell responses were also evaluated following endothelial-specific VCAM1 deletion. Plasma soluble VCAM1 (sVCAM1) was measured in patients with unruptured and ruptured bAVMs and unruptured aneurysm controls. Effects of sVCAM1 on MG activation were examined in vitro. RESULTS: Integrated human endothelial bulk and single-cell RNA-sequencing and tissue validation identified VCAM1 upregulation in bAVMs, including unruptured lesions. Plasma analyses showed increased sVCAM1 in unruptured and ruptured bAVM patients compared with unruptured aneurysm controls. In mutant KRAS-induced bAVM mice, transcriptomic and proteomic analyses demonstrated increased VCAM1 expression, with endothelial localization confirmed histologically. In vitro, mutant KRAS increased sVCAM1 production, while recombinant sVCAM1 stimulated inflammatory mediator expression in MG. Both MG and M{varphi} expressed VLA-4, a major VCAM1 receptor. Intravital imaging showed that VCAM1 neutralization reduced M{varphi} accumulation and MG activation, while early VCAM1 neutralization reduced hemorrhagic burden. Consistently, endothelial-specific VCAM1 deletion reduced M{varphi} accumulation, MG activation, and hemorrhage volume in bAVM mice and improved behavioral performance. CONCLUSIONS: These findings identify endothelial VCAM1 as an upstream mediator linking mutant KRAS signaling to myeloid cell responses and hemorrhagic progression in bAVMs. This study establishes endothelial VCAM1 as a potential therapeutic target for attenuating hemorrhagic progression.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Eun S. Park has the highest h-index among the authors (20).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.